Gilead, Kite and oNKo-innate Announce Research Collaboration to Discover Cancer Immunotherapies Focused on NK Cells Read more
Anixa Biosciences and OntoChem Announce Collaboration to Develop Novel COVID-19 Therapeutics Read more
Alexion Announces Plans To Initiate Phase 3 Study Of Ultomiris In Hospitalized Patients With Severe Covid-19 Read more
Wavelength Pharmaceuticals Expands Supplies of Key Drug Ingredients for Critically Ill COVID-19 Patients Read more
FDA and EMA accept applications for Roche’s OCREVUS (ocrelizumab) shorter 2-hour infusion time Read more